ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2026; 16(4): 160-174


Development and evaluation of Python language processed automated disproportionality analysis system for FAERS database

Avinash Laddha, Deepak Gurram, Rajalakshmi Rajendran, Muhammed Rashid, Pooja Gopal Poojari, Sreedharan Nair, Sohil Khan, Krishnan Subramonian, Madamanchi Chandra Vardhan, Richa Jackeray, Girish Thunga.



Abstract
Download PDF Post

he limitations of existing disproportionality analysis methods for Food and Drug Administration Adverse Event Reporting System (FAERS) data highlight the need for automated tools for efficient data mining and analysis. This study aimed to develop and validate an automated Python-based tool for FAERS data processing. The methodology included: (i) Automation development and signal detection using Python and (ii) Validation through traditional disproportionality analysis. Public FAERS quarterly extract files from 2004 (Q1) to 2021 (Q4) were accessed, matched, and deduplicated using a multi-step approach. The cleaned dataset was analysed using a contingency table to compute reporting odds ratios, PRR, Chi-square statistics, and 95% confidence intervals. Validation confirmed that results from the automated tool matched traditional analysis. Using Remdesivir as an example, we identified 12,777 adverse events and 256 safety signals. The tool offers multiple advantages: simplified coding, minimal storage requirements, cloud-based execution (Google Colab), accessibility for non-technical users, rapid processing, tailored signal detection, and automated FAERS updates. The extreme deduplication process ensures refined results, aligning with pre-defined criteria. This validated tool can significantly enhance pharmacovigilance research and regulatory decision-making, with potential for broader adoption through user-friendly desktop interfaces.

Key words: Adverse event; Disproportionality analysis; FAERS; Risk assessment







Bibliomed Article Statistics

27
R
E
A
D
S

24
D
O
W
N
L
O
A
D
S
03
2026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.